Osteopromotion by a beta-tricalcium phosphate/bone marrow hybrid implant for use in spine surgery
- PMID: 16395170
- DOI: 10.1097/01.brs.0000192762.40274.57
Osteopromotion by a beta-tricalcium phosphate/bone marrow hybrid implant for use in spine surgery
Erratum in
- Spine. 2006 Apr 20;31(9):1065. Igor, Ponomarev [corrected to Ponomarev, Igor]; Thierry, Stoll [corrected to Stoll, Thierry]; Ingo, Wilke [corrected to Wilke, Ingo]
Abstract
Study design: Experimental animal study. OBJECTIVE.: Evaluate osteopromotive properties of a beta-tricalcium phosphate (TCP) implant with different osteogenic substances in an animal study.
Summary of background data: Current research in spine surgery is focusing on resorbable bone implants because of the high morbidity after iliac crest graft harvesting. Therefore, several osteoconductive scaffolds are combined with osteoinductive substances.
Methods: In 14 sheep, a critical size defect was performed on both tibiae. The sheep were randomized into 3 groups (4 sheep each) and a control group (2 sheep). In the treatment groups, the defects were filled with the beta-TCP scaffold impregnated with either venous blood, bone marrow from sternal aspiration, or a concentrated mononuclear cell suspension derived from sternal bone marrow aspiration. The sheep in each group were euthanized 6 and 12 weeks after the operation; the investigation included quantitative computerized tomography and histology.
Results: The best bone formation occurred in the bone marrow group after 6 and 12 weeks, whereas no difference was found between the cell and venous blood groups. Only the bone marrow group showed bone formation inside the scaffold after 6 weeks. We conclude that a beta-TCP scaffold filled with bone marrow aspiration creates a biologic resorbable bone substitute with high osteopromoting capacity. Surprisingly, no better bone formation occurred in the concentrated cells group, which may be a result of technical reasons and needs to be further evaluated.
Conclusions: The combination of beta-TCP and bone marrow has superior osteopromotive properties to venous blood or concentrated mononuclear cells and can be used effectively as a substitute to iliac crest graft.
Similar articles
-
Osteopromotion with a plasmatransglutaminase on a beta-TCP ceramic.J Mater Sci Mater Med. 2008 Feb;19(2):659-65. doi: 10.1007/s10856-007-3223-2. Epub 2007 Jul 10. J Mater Sci Mater Med. 2008. PMID: 17619952
-
Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery.Eur Spine J. 2001 Oct;10 Suppl 2(Suppl 2):S132-40. doi: 10.1007/s005860100325. Eur Spine J. 2001. PMID: 11716010 Free PMC article.
-
In vivo evaluation of bone marrow stromal-derived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion.Spine (Phila Pa 1976). 2003 Aug 1;28(15):1653-8. doi: 10.1097/01.BRS.0000083168.37329.B4. Spine (Phila Pa 1976). 2003. PMID: 12897487
-
Bone marrow stromal cells and their use in regenerating bone.Novartis Found Symp. 2003;249:133-43; discussion 143-7, 170-4, 239-41. Novartis Found Symp. 2003. PMID: 12708654 Review.
-
Molecular basis for action of bioactive glasses as bone graft substitute.Scand J Surg. 2006;95(2):95-102. doi: 10.1177/145749690609500204. Scand J Surg. 2006. PMID: 16821652 Review.
Cited by
-
Hydroxyapatite/collagen composite graft for posterior lumbar interbody fusion: a comparison with local bone graft.J Orthop Surg Res. 2021 Oct 24;16(1):639. doi: 10.1186/s13018-021-02798-4. J Orthop Surg Res. 2021. PMID: 34689807 Free PMC article.
-
Identification of mesenchymal stem cells and osteogenic factors in bone marrow aspirate and peripheral blood for spinal fusion by flow cytometry and proteomic analysis.J Orthop Surg Res. 2014 May 3;9:32. doi: 10.1186/1749-799X-9-32. J Orthop Surg Res. 2014. PMID: 24886437 Free PMC article.
-
Cell therapy: A potential solution for the healing of bone cavities.Heliyon. 2021 Jan 5;7(1):e05885. doi: 10.1016/j.heliyon.2020.e05885. eCollection 2021 Jan. Heliyon. 2021. PMID: 33474509 Free PMC article.
-
In vitro comparison of three rifampicin loading methods in a reinforced porous β-tricalcium phosphate scaffold.J Mater Sci Mater Med. 2015 Apr;26(4):174. doi: 10.1007/s10856-015-5437-z. Epub 2015 Mar 28. J Mater Sci Mater Med. 2015. PMID: 25820665
-
Autologous bone marrow clot as an alternative to autograft for bone defect healing.Bone Joint Res. 2019 Apr 2;8(3):107-117. doi: 10.1302/2046-3758.83.BJR-2018-0096.R1. eCollection 2019 Mar. Bone Joint Res. 2019. PMID: 30997036 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials